UB Paderborn / Katalog / Suche / in CDI

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis

AIDS (London), 2021-07, Vol.35 (9), p.1333-1342

2021

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study

HIV research & clinical practice, 2019-09, Vol.20 (4-5), p.111-122

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

The New England journal of medicine, 2020-03, Vol.382 (12), p.1124-1135

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

The Lancet (British edition), 2017-09, Vol.390 (10101), p.1499-1510

2017

Link zum Volltext

Verfügbarkeit prüfen

Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks

AIDS and behavior, 2020-12, Vol.24 (12), p.3533-3544

2020

Link zum Volltext

Verfügbarkeit prüfen

The Major Premiership: Politics and Policies under John Major, 1990-97

Dorey, Peter

1, 1999

Link zum Volltext

Verfügbarkeit prüfen

1035. Patient-Reported Outcomes on Long-Acting Cabotegravir + Rilpivirine as Maintenance Therapy: FLAIR 96-Week Results

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S548-S548

2020

Link zum Volltext

Verfügbarkeit prüfen

1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S544-S544

2020

Link zum Volltext

Verfügbarkeit prüfen

884. Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine Through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S20-S20

2019

Link zum Volltext

Verfügbarkeit prüfen

P032: Dolutegravir versus raltegravir in ARV-experienced INI-naïve HIV+ adults: 48-week subgroup analysis of Latin American subjects in the SAILING study

Journal of the International AIDS Society, 2015-04, Vol.18 (3 (Suppl 2))

2015

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

The Lancet (British edition), 2013, Vol.382 (9893), p.700-708

2013

Link zum Volltext

Verfügbarkeit prüfen

Reciprocal Relations of Subcutaneous and Visceral Fat to Bone Structure and Strength

The journal of clinical endocrinology and metabolism, 2009-09, Vol.94 (9), p.3387-3393

2009

Link zum Volltext

Verfügbarkeit prüfen

First observations on the life cycle and mass eclosion events in a mantis fly (Family Mantispidae) in the subfamily Drepanicinae

Biodiversity data journal, 2017-11, Vol.5 (5), p.e21206-e21206

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2006-11, Vol.296 (19), p.2351

2006

Link zum Volltext

Verfügbarkeit prüfen

Controlled Sonication as a Route to in-situ Graphene Flake Size Control

Scientific reports, 2019-06, Vol.9 (1), p.8710-8, Article 8710

2019

Link zum Volltext

Verfügbarkeit prüfen

Function matters: a review of terminological differences in applied and basic clicker training research

PeerJ (San Francisco, CA), 2018-09, Vol.6, p.e5621-e5621, Article e5621

2018

Link zum Volltext

Verfügbarkeit prüfen

Magnetic Resonance Imaging-Ultrasound Fusion Biopsy for Prediction of Final Prostate Pathology

The Journal of urology, 2014-11, Vol.192 (5), p.1367-1373

2014

Link zum Volltext

Verfügbarkeit prüfen

A matrix model for WZW

The journal of high energy physics, 2016-08, Vol.2016 (8), p.1-31, Article 7

2016

Link zum Volltext

Verfügbarkeit prüfen

Development and internal validation of a model for postoperative morbidity in adults undergoing major elective colorectal surgery: the peri‐operative quality improvement programme (PQIP) colorectal risk model

Anaesthesia, 2022-12, Vol.77 (12), p.1356-1367

2022

Link zum Volltext

Verfügbarkeit prüfen

Obesity and Outcome in Pediatric Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2063-2069

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks

Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study

Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure

The Major Premiership: Politics and Policies under John Major, 1990-97

1035. Patient-Reported Outcomes on Long-Acting Cabotegravir + Rilpivirine as Maintenance Therapy: FLAIR 96-Week Results

1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies

884. Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine Through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies

Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis across three phase 3 studies

P032: Dolutegravir versus raltegravir in ARV-experienced INI-naïve HIV+ adults: 48-week subgroup analysis of Latin American subjects in the SAILING study

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Reciprocal Relations of Subcutaneous and Visceral Fat to Bone Structure and Strength

First observations on the life cycle and mass eclosion events in a mantis fly (Family Mantispidae) in the subfamily Drepanicinae

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

Controlled Sonication as a Route to in-situ Graphene Flake Size Control

Function matters: a review of terminological differences in applied and basic clicker training research

Early and very early‐onset schizophrenia compared with adult‐onset schizophrenia: French FACE‐SZ database

Magnetic Resonance Imaging-Ultrasound Fusion Biopsy for Prediction of Final Prostate Pathology

A matrix model for WZW

Development and internal validation of a model for postoperative morbidity in adults undergoing major elective colorectal surgery: the peri‐operative quality improvement programme (PQIP) colorectal risk model

Obesity and Outcome in Pediatric Acute Lymphoblastic Leukemia

Suchergebnisse filtern